A Post-Marketing Observational Study to Evaluate the Effectiveness of Adalimumab in Patients With Moderately to Severely Active Rheumatoid Arthritis in China
This study has been terminated.
(This study was prematurely terminated due to low enrollment)
AbbVie (prior sponsor, Abbott)
First Posted: November 3, 2011
Last Update Posted: March 6, 2014
Information provided by (Responsible Party):
AbbVie ( AbbVie (prior sponsor, Abbott) )